. 2024 Oct 15;17:2283–2296. doi: 10.2147/CCID.S474331

Table 2.

Change of GEA and Total, Inflammatory and Non-Inflammatory Lesion Counts from Baseline Across Treatment Groups

Change from baseline		Group									p-value
		A			B			C
		n	Mean	SD	n	Mean	SD	n	Mean	SD
GEA	D28	96	0.15	0.52	95	0.21	0.48	94	0.35	0.50	A-B=0.325 A-C=0.007* B-C=0.072^@
GEA	D56	96	0.52	0.62	95	0.47	0.70	94	0.69	0.61	A-B=0.681 A-C=0.052^§ B-C=0.024**
Total lesion count	D28	96	5.40	20.49	95	7.72	14.50	94	8.69	15.99	A-B=0.257 A-C=0.453 B-C=0.502
Total lesion count	D56	96	18.33	17.95	95	17.37	19.76	94	17.41	19.85	A-B=0.775 A-C=0.695 B-C=0.950
Inflammatory lesion count	D28	96	2.90	6.12	95	3.13	6.86	94	3.40	7.24	A-B=0.648 A-C=0.257 B-C=0.505
Inflammatory lesion count	D56	96	4.47	6.13	95	4.78	8.09	94	5.31	8.74	A-B=0.638 A-C=0.389 B-C=0.674
Non-Inflammatory lesion count	D28	96	2.51	18.20	95	4.59	11.68	94	5.29	12.75	A-B=0.581 A-C=0.578 B-C=0.891
Non-Inflammatory lesion count	D56	96	13.86	15.81	95	12.59	15.31	94	12.10	14.65	A-B=0.967 A-C=0.734 B-C=0.895

Notes: For Group C (values in bold): *statistically significant (p<0.05) compared to Group A; ^@tendency towards significance (p=0.072) compared to Group B; ^§tendency towards significance (p=0.052) compared to Group A; **statistically significant (p<0.05) compared to Group B.